5-Bromo-2-Chloro-4′-Ethoxydiphenylmethane CAS 461432-23-5 Dapagliflozin Intermediate Factory

Kufotokozera Kwachidule:

Dzina: 5-Bromo-2-Chloro-4′-Ethoxydiphenylmethane

Mawu ofanana nawo: 4-Bromo-1-Chloro-2-(4-Ethoxybenzyl)benzene

CAS: 461432-23-5

Kuyera: ≥99.0% (HPLC)

Maonekedwe: Ufa Woyera mpaka Pael Yellow Crystalline

Wapakatikati wa Dapagliflozin (CAS: 461432-26-8) pochiza matenda a shuga a mtundu II

Ubwino Wapamwamba, Kupanga Zamalonda

Inquiry: alvin@ruifuchem.com


Tsatanetsatane wa Zamalonda

Zogwirizana nazo

Zolemba Zamalonda

Kufotokozera:

Wopanga Zinthu, Kuyera Kwambiri, Kupanga Zamalonda
Dapagliflozin (CAS: 461432-26-8) Zowonjezera Zogwirizana:
5-Bromo-2-Chlorobenzoic Acid CAS 21739-92-4
5-Bromo-2-Chloro-4'-Ethoxydiphenylmethane CAS 461432-23-5
2,3,4,6-Tetrakis-O-Trimethylsilyl-D-Gluconolactone CAS 32384-65-9

Chemical Properties:

Dzina la Chemical 5-Bromo-2-Chloro-4'-Ethoxydiphenylmethane
Mawu ofanana ndi mawu 4-Bromo-1-Chloro-2-(4-Ethoxybenzyl)benzene;4-(5-Brom-2-Chlorbenzyl)phenyl-Ethylether;Dapagliflozin Bromo Impurity
Nambala ya CAS 461432-23-5
Nambala ya CAT RF-PI447
Stock Status Mu Stock, Kupanga Kukula Mpaka Matani
Molecular Formula Chithunzi cha C15H14BrClO
Kulemera kwa Maselo 325.63
Melting Point 41.0 mpaka 43.0 ℃
Mtundu Ruifu Chemical

Zofotokozera:

Kanthu Zofotokozera
Maonekedwe Ufa Woyera mpaka Pael Yellow Crystalline
Kuyera / Kusanthula Njira ≥99.0% (HPLC)
Madzi (KF) ≤0.50%
Zonse Zonyansa ≤1.0%
Test Standard Enterprise Standard
Kugwiritsa ntchito Wapakatikati wa Dapagliflozin (CAS: 461432-26-8), mtundu II shuga mellitus

Phukusi & Kusunga:

Phukusi: Botolo, Aluminiyamu zojambulazo thumba, makatoni Drum, 25kg/ng'oma, kapena malinga ndi zofuna za kasitomala.

Mkhalidwe Wosungira:Sungani m'mitsuko yosindikizidwa pamalo ozizira ndi owuma;Tetezani ku kuwala ndi chinyezi.

Ubwino:

1

FAQ:

Ntchito:

4-Bromo-1-Chloro-2-(4-Ethoxybenzyl)benzene (CAS: 461432-23-5) amagwiritsidwa ntchito ngati wapakatikati pakuphatikizika kwa Dapagliflozin (CAS: 461432-26-8).Dapagliflozin ndi choletsa champhamvu, chosankha aimpso chodalira glucose cotransporter 2 (SGLT2) pochiza matenda amtundu wa 2.Dapagliflozin ndi mankhwala atsopano oletsa shuga omwe amapangidwa molumikizana ndi Bristol-Myers Squibb ndi AstraZeneca, kuvomerezedwa ndi European Medicines Agency (EMA) pa Novembara 12, 2012. Pa Januware 8, 2014, US Food and Drug Administration (FDA) idavomereza. kuti agwiritsidwe ntchito pochiza matenda amtundu wa II.

Lembani uthenga wanu apa ndikutumiza kwa ife